Nurse Practitioner, Family · Lavale, MD
NPI
1558790485
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
921 Seton Drive
Lavale, MD, 21502
Phone (301) 724-4337
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
102,688 services
Medicare patients, 2024
585
Average age 74
Drug cost, 2024
$1.9M
1,618 prescriptions
Company payments, 2025
$1,414
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brandi L Haas was code J0897 (injection, denosumab, 1 mg), 25,560 times for 249 patients. In total Brandi L Haas billed 102,688 services in 39 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 25,560 | 249 | $20.48 | $524K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 19,525 | 26 | $33.86 | $661K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 6,080 | 19 | $24.90 | $151K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,480 | 25 | $0.10 | $149 |
| 99214 Office E&M - Established | Office | 782 | 419 | $80.60 | $63K |
| 96372 Injection Administration | Office | 725 | 282 | $9.43 | $6,835 |
| 96365 Intravenous Infusion, Hydration | Office | 324 | 67 | $41.96 | $14K |
| 36415 Venipuncture Blood Collection | Office | 252 | 60 | $8.65 | $2,180 |
| 96413 Chemotherapy Administration | Office | 199 | 31 | $87.13 | $17K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 175 | 35 | $4.75 | $831 |
| 96415 Chemotherapy Administration | Office | 172 | 24 | $18.63 | $3,204 |
| 99204 Office E&M - New | Office | 66 | 66 | $104.49 | $6,896 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 13 | 12 | $4.65 | $60.48 |
By year: 2022 $15K for 278 services; 2023 $575K for 32,212 services; 2024 $2.5M for 102,688 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 252 | 60 | $8.65 | $2,180 |
Medicare prescription drug claims, 2024
In 2024, the drug Brandi L Haas prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 282 prescriptions and refills. In total Brandi L Haas wrote 1,618 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 282 | 735 | 82 | $8,666 |
| Hydroxychloroquine Sulfate Generic | 238 | 649 | 76 | $11K |
| Prednisone Generic | 205 | 434 | 96 | $2,254 |
| Leflunomide Generic | 59 | 177 | 19 | $3,963 |
| Colchicine Generic | 58 | 134 | 25 | $4,274 |
| Allopurinol Generic | 47 | 133 | 15 | $617 |
| Duloxetine Hcl Generic | 44 | 113 | 17 | $1,805 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 40 | 45 | Under 11 | $337K |
| Enbrel Sureclick Etanercept | 37 | 37 | Under 11 | $272K |
| Humira(Cf) Pen Adalimumab | 36 | 43 | Under 11 | $495K |
| Folic Acid Generic | 32 | 96 | 13 | $387 |
| Meloxicam Generic | 29 | 56 | Under 11 | $199 |
| Otezla Apremilast | 29 | 29 | Under 11 | $142K |
| Sulfasalazine Generic | 23 | 69 | Under 11 | $917 |
| Celecoxib Generic | 22 | 58 | Under 11 | $567 |
Brand drugs: - claims; generic drugs: 1,333 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brandi L Haas $1,414 ($1,414 in general payments such as food, travel and fees) from 13 companies. The largest payer was Amgen Inc. with $491.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 15 | $491 |
| Abbvie Inc. ABBV | 15 | $281 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $122 |
| Boston Scientific Corporation BSX | 1 | $120 |
| Inspire Medical Systems, Inc. INSP | 2 | $76.13 |
| Janssen Biotech, Inc. JNJ | 4 | $74.81 |
| UCB, Inc. UCB.BR | 3 | $69.97 |
| GlaxoSmithKline, LLC. GSK | 2 | $61.93 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $56.78 |
| Lilly USA, LLC LLY | 1 | $28.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.